Australia markets close in 1 hour 35 minutes
  • ALL ORDS

    7,440.50
    -47.20 (-0.63%)
     
  • ASX 200

    7,248.10
    -43.20 (-0.59%)
     
  • AUD/USD

    0.6691
    -0.0004 (-0.07%)
     
  • OIL

    74.08
    -0.17 (-0.23%)
     
  • GOLD

    1,783.00
    +0.60 (+0.03%)
     
  • BTC-AUD

    25,451.67
    -195.62 (-0.76%)
     
  • CMC Crypto 200

    401.74
    -0.07 (-0.02%)
     
  • AUD/EUR

    0.6394
    +0.0012 (+0.18%)
     
  • AUD/NZD

    1.0583
    +0.0001 (+0.01%)
     
  • NZX 50

    11,637.02
    +5.42 (+0.05%)
     
  • NASDAQ

    11,549.69
    -237.11 (-2.01%)
     
  • FTSE

    7,521.39
    -46.15 (-0.61%)
     
  • Dow Jones

    33,596.34
    -350.76 (-1.03%)
     
  • DAX

    14,343.19
    -104.42 (-0.72%)
     
  • Hang Seng

    19,437.24
    -3.94 (-0.02%)
     
  • NIKKEI 225

    27,756.94
    -128.93 (-0.46%)
     

Tactile Medical to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

Tactile Systems Technology, Inc.
Tactile Systems Technology, Inc.

MINNEAPOLIS, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today announced that management will participate in the Morgan Stanley 20th Annual Global Healthcare Conference, which is being held at the Sheraton New York Times Square Hotel in New York, NY from September 12th-14th. Management will participate in a fireside chat on Tuesday, September 13th at 11:10 a.m. Eastern Time.

A live audio webcast of the presentation will be accessible under the “Events & Webcasts” section of the Company's investor relations website at http://investors.tactilemedical.com. An archive of the webcast will be available for replay following the conference.

About Tactile Medical

Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease by helping them live better and care for themselves at home. The company collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year.

CONTACT: Investor Inquiries: Mike Piccinino, CFA Managing Director ICR Westwicke investorrelations@tactilemedical.com